Literature DB >> 16700086

Developments of the incidence of osteoporosis in The Netherlands: a PHARMO study.

Wim G Goettsch1, Romy B de Jong, Piotr Kramarz, Ron M C Herings.   

Abstract

PURPOSE: To assess recent and to predict future time trends in the incidence of osteoporosis using routine databases in The Netherlands in the period 1993-2015 and to compare estimations based on hip fractures versus a proxy based on pharmacy and hospitalisation data.
METHODS: The incidence of hip fractures was estimated over the period 1986-2002 using information from the Dutch Medical Registry, covering more than 99% of all Dutch hospitalisations. Additionally, a proxy (hospitalisation for osteoporosis or osteoporotic fractures, treatment with glucocorticosteroids or treatment with anti-osteoporosis drugs) was constructed in order to identify osteoporotic patients in the PHARMO database. Age and gender specific incidences of hip fractures and osteoporosis were calculated and extrapolated to The Netherlands. Results of both studies were extrapolated till 2015 using a power function.
RESULTS: The incidence of hip fractures decreased slightly (270 per 100,000 in 1993, 260 per 100,000 in 2002). The incidence of osteoporosis using the constructed proxy decreased from 870 per 100,000 in 1993 to 700 per 100,000 in 2002. The incidence of hip fractures and osteoporosis remained fairly constant when modelled till 2015. Both studies showed the same time trends.
CONCLUSION: Both the estimations based on the hospitalisations for hip fracture and on our proxy for osteoporosis showed that the increase in the incidence of osteoporosis as observed in the 1990s is levelling off. Due to ageing of the population the absolute number of hip fractures will however increase. Our definition of osteoporosis resulted in a higher estimation of the incidence of osteoporosis and may be used in future studies to follow developments in osteoporosis prevalence and incidence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16700086     DOI: 10.1002/pds.1245

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  16 in total

1.  Validation of a case definition for osteoporosis disease surveillance.

Authors:  W D Leslie; L M Lix; M S Yogendran
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study.

Authors:  Nam-Kyong Choi; Daniel H Solomon; Theodore N Tsacogianis; Joan E Landon; Hong Ji Song; Seoyoung C Kim
Journal:  J Bone Miner Res       Date:  2017-02-07       Impact factor: 6.741

3.  Age-adjusted incidence rates of hip fractures between 2006 and 2009 in Rabat, Morocco.

Authors:  A El Maghraoui; A R Ngbanda; N Bensaoud; M Bensaoud; A Rezqi; M A Tazi
Journal:  Osteoporos Int       Date:  2012-06-27       Impact factor: 4.507

4.  Increasing age- and sex-specific rates of hip fracture in Mexico: a survey of the Mexican Institute of Social Security.

Authors:  H Johansson; P Clark; F Carlos; A Oden; E V McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2010-12-21       Impact factor: 4.507

Review 5.  Secular trends in the incidence of hip and other osteoporotic fractures.

Authors:  C Cooper; Z A Cole; C R Holroyd; S C Earl; N C Harvey; E M Dennison; L J Melton; S R Cummings; J A Kanis
Journal:  Osteoporos Int       Date:  2011-04-02       Impact factor: 4.507

6.  Epidemiology of fragility fractures in Sakaiminato, Japan: incidence, secular trends, and prognosis.

Authors:  Y Tsukutani; H Hagino; Y Ito; H Nagashima
Journal:  Osteoporos Int       Date:  2015-05-19       Impact factor: 4.507

7.  Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people.

Authors:  Kristina Johnell; Johan Fastbom
Journal:  Arch Osteoporos       Date:  2009-03-19       Impact factor: 2.617

8.  Geographical variations in hip fracture risk for women: strong effects hidden in standardised ratios.

Authors:  S Barbier; R Ecochard; A-M Schott; C Colin; P D Delmas; S B Jaglal; C M Couris
Journal:  Osteoporos Int       Date:  2008-07-18       Impact factor: 4.507

9.  Secular trends in fracture incidence in the UK between 1990 and 2012.

Authors:  R Y van der Velde; C E Wyers; E M Curtis; P P M M Geusens; J P W van den Bergh; F de Vries; C Cooper; T P van Staa; N C Harvey
Journal:  Osteoporos Int       Date:  2016-06-09       Impact factor: 4.507

10.  Geographic differences in fractures among women.

Authors:  Anna Litwic; Mark Edwards; Cyrus Cooper; Elaine Dennison
Journal:  Womens Health (Lond)       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.